Univariate logistic regression analysis showed that high SMYD3 expression was associated with a poor response (PD and SD) to chemotherapy in DLBCL [odds ratio (OR) = 4.818; 95% CI, 1.434–16.193; P = 0.011; Table S6)]. This evidence concerns the gene SMYD3 and diffuse large B-cell lymphoma.